XML 75 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]        
Revenues $ 59,172 $ 56,208 $ 172,516 $ 161,890
Cost of Sales (56,139) (53,238) (163,829) (153,337)
Gross Profit 3,033 2,970 8,687 8,553
Operating Expenses (2,535) (2,156) (6,861) (6,219)
Goodwill Impairment Charges (2) (21) (2) (591)
Restructuring, Impairment and Related Charges (136) (110) (204) (288)
Total Operating Expenses (2,673) (2,287) (7,067) (7,098)
Operating Income 360 683 1,620 1,455
Other Income (Expense), Net 26 84 (15) 144
Equity Earnings and Charges from Investment in Change Healthcare Joint Venture (28) (50) (1,478) (162)
Interest Expense (64) (67) (184) (194)
Income (Loss) from Continuing Operations Before Income Taxes 294 650 (57) 1,243
Income Tax Benefit (Expense) (47) (123) 111 (245)
Income from Continuing Operations 247 527 54 998
Income (Loss) from Discontinued Operations, Net of Tax (5) (1) (12) 1
Net Income 242 526 42 999
Net Income Attributable to Noncontrolling Interests (56) (57) (163) (169)
Net Income (Loss) Attributable to McKesson Corporation $ 186 $ 469 $ (121) $ 830
Diluted        
Continuing operations (in dollars per share) $ 1.06 $ 2.41 $ (0.60) $ 4.17
Discontinued operations (in dollars per share) (0.03) (0.01) (0.06) 0.01
Total (in dollars per share) 1.03 2.40 (0.66) 4.18
Basic        
Continuing operations (in dollars per share) 1.06 2.42 (0.60) 4.19
Discontinued operations (in dollars per share) (0.02) (0.01) (0.06) 0
Total (in dollars per share) $ 1.04 $ 2.41 $ (0.66) $ 4.19
Weighted Average Common Shares        
Diluted (in shares) 180 195 183 199
Basic (in shares) 179 194 183 198